Is GE HealthCare (GEHC) overvalued or fairly valued?

MarketChacha shows GE HealthCare's valuation in context — a forward P/E of about 11.5, a price-to-book of about 2.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of GE HealthCare (GEHC)?

GE HealthCare last traded at $61.53 (-0.8% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

GE HealthCare

GEHC · NASDAQ · Healthcare · United States

$61.53-0.8%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:36 PM

Snapshot

TickerGEHC

ExchangeNASDAQ

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees54,000

HeadquartersChicago, United States

Market cap$28.0B

P/B2.6

Volume1.12M

Websitewww.gehealthcare.com

Filings tracked0

About GE HealthCare

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.4%
Institutions95.6%
Public & other4.1%

1,725 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.7.91%
Dodge & Cox Inc.6.88%
Vanguard Capital Management LLC6.35%
Capital Research Global Investors4.64%
State Street Corporation4.52%
Vanguard Portfolio Management LLC4.22%
Invesco Ltd.3.80%
Harris Associates L.P.3.43%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $5.4B · EPS 1.24

Est. earnings growth +16.2%

Next fiscal year

Rev $22.8B · EPS 5.36

Est. earnings growth +10.0%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$58.7552-wk range$89.77

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about GEHC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.